TransCorp Spine Surgical System Attracts National Peer-Review Award – Grand Rapids Business Journal

December 25, 2012 The Brain + Spine Center in Holland Township has announced that the SpinePort surgical system co-invented by the clinic’s neurosurgeon, Dr. David W. Lowry, and physician assistant Scott M. Tuinstra has received […]

Read On ›

Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation

KALAMAZOO, Mich., Oct. 16, 2012 — /PRNewswire/ – Tolera Therapeutics Inc., a privately held biotechnology company focusing on the development of immunotherapeutics directed at the transplantation, autoimmune and oncology markets, announced today that it has closed […]

Read On ›

NeoChord Inc. Obtains Exclusive Rights to State-of-the-Art, Award-Winning ‘Augmented Reality’ Imaging Technology from Western University’s Robarts Research Institute

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Robust navigation platform integrates real-time transesophageal echo (TEE) with a magnetic tracking system that guides a surgeon to virtual images of target anatomy. “The ‘NeoNav’ imaging platform offers faster and easier navigation […]

Read On ›

Tolera Therapeutics Announces Appointment of Linda C. Hogan as Vice President, Business Development

KALAMAZOO, Mich., Oct. 1, 2012 – /PRNewswire/ – Tolera Therapeutics, Inc., a privately held biotechnology company focused on the development of immunotherapeutics directed at the transplantation, autoimmune and oncology markets announced today the appointment of Linda C. […]

Read On ›

Hopen Life Science Ventures Expands Leadership Team with Addition of Michael Fulton, M.D. as Managing Director; Opens Cleveland, Ohio Office to Strengthen Midwest Reach

Cleveland, OH (September 18, 2012) – Hopen Life Science Ventures, a Midwest-based venture capital firm, is pleased to announce the addition of Michael Fulton, M.D. as a managing director. Dr. Fulton has over 20 years […]

Read On ›

NeoChord Completes Enrollment for ‘TACT’ Clinical Trial

September 10, 2012 10:00 AM Eastern Daylight Time EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–   Acute and chronic results using NeoChord’s sternal-sparing, beating-heart, mitral valve repair system to implant artificial chordae tendinae are encouraging. NeoChord: “The 30-patient TACT […]

Read On ›

MSDC Presents Update on Ongoing Clinical Evaluation of First in Class mTOT Modulator™ in Mild Alzheimer’s Disease at 13th International Conference on Alzheimer’s Drug Discovery

KALAMAZOO, Mich., Sept. 7, 2012 /PRNewswire/ — Metabolic Solutions Development Company, LLC (MSDC) will provide an update on the clinical evaluation of MSDC-0160, a first in class mTOT Modulator™ that is being investigated in an […]

Read On ›

Researchers Study Potential New Therapeutic Target for Alzheimer’s Disease

KALAMAZOO, Mich., June 21, 2012 – Physicians at medical centers in Kalamazoo and Grand Rapids are helping to identify interested individuals for participation in a clinical trial of a novel drug therapy for patients with […]

Read On ›

TransCorp Spine Receives FDA 510(k) Clearance for the SpinePort™

Ada, Michigan – TransCorp Spine announced today that it received FDA 510(k) clearance for its SpinePort Spinal Access System.  The SpinePort System provides direct access and visualization to aide surgeons in treating cervical spine pathologies […]

Read On ›

Metabolic Solutions Development Company Novel Insulin Sensitizer Meets Phase 2b Study Endpoints And Affirms New Mechanism Of Action

PHILADELPHIA, June 9, 2012 – Metabolic Solutions Development Company, LLC (MSDC) presented Phase 2b results for MSDC-0160 today at the 72nd Scientific Sessions of the American Diabetes Association. The data showed this novel once-a-day oral […]

Read On ›